title: ¹⁸F-FDG-PET/CT in malignant mesothelioma.
abstract: It is well known the useful role of ¹⁸F-FDG-PET/CT for differential diagnosis between benign and malignant disease, for staging, for monitoring response and for prognosis regarding mesothelioma. Recently, literature was enriched with new interesting studies regarding the potential applications of ¹⁸F-FDG-PET/CT in this field. The purpose of this review is to evaluate articles published on line (PubMed) from January 2011 until October 2012 in order to obtain an overview of recent progress of molecular imaging in malignant mesothelioma. The main topics concern the use of ¹⁸F-FDG-PET/CT in radiation therapy planning, monitoring of treatment (surgery/chemotherapy) response and prognosis assessment.
authors.affiliation: Nuclear Medicine Unit, Fondazione Salvatore Maugeri, Pavia, Italy. chiara.fuccio@gmail.com
authors.forename: Chiara
authors.initials: C
authors.lastname: Fuccio
authors.forename: Elena Giulia
authors.initials: EG
authors.lastname: Spinapolice
authors.forename: Alice
authors.initials: A
authors.lastname: Ferretti
authors.forename: Paolo
authors.initials: P
authors.lastname: Castellucci
authors.forename: Maria Cristina
authors.initials: MC
authors.lastname: Marzola
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Trifirò
authors.forename: Domenico
authors.initials: D
authors.lastname: Rubello
mesh_terms: D019788:Fluorodeoxyglucose F18 / Q000008:administration & dosage*; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D008654:Mesothelioma / Q000000981:diagnostic imaging* / Q000473:pathology; D000086002:Mesothelioma, Malignant; D049268:Positron-Emission Tomography / Q000379:methods; D011379:Prognosis; D019275:Radiopharmaceuticals / Q000008:administration & dosage*; D014057:Tomography, X-Ray Computed / Q000379:methods
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: (18)F-FDG-PET/CT; Malignant mesothelioma; Prognosis; Radiation therapy planning; Treatment response